16Jul/13

Prostate Cancer ADT Found to Boost Acute Kidney Injury Risk – Renal and Urology News


Toronto NewsFIX

Prostate Cancer ADT Found to Boost Acute Kidney Injury Risk
Renal and Urology News
Prostate cancer patients on androgen deprivation therapy (ADT) are at increased risk of acute kidney injury (AKI), according to a new study published in the Journal of the American Medical Association. The study, by Francesco Lapi, PharmD, PhD, of
Study raises red flag regarding commonly used prostate cancer therapyCape Breton Post
Hormone reduction for prostate cancer may harm kidneysLos Angeles Times
Hormone Use in Prostate Cancer May Harm KidneysMedPage Today
U.S. News & World Report –Doctors Lounge
all 14 news articles »
16Jul/13

Six steps could cut heart failure readmissions – Medical Xpress


Counsel & Heal

Six steps could cut heart failure readmissions
Medical Xpress
There are six procedural things hospital teams can do to help heart failure patients avoid another hospital stay in the 30 days after they’re discharged—and if all six are followed, patients are even more likely to avoid readmission, according to new
Report Reveals 6 Steps for Hospitals to Cut Heart Failure ReadmissionsCounsel & Heal
Six strategies for reducing hospital readmissions among elderlyHealthCanal.com
Yale study identifies ways to prevent Medicare patient readmissionNew Haven Register
MedPage Today
all 5 news articles »
16Jul/13

Multiple Sclerosis Drug Shows Promise for Preventing Heart Failure – Science Daily (press release)

Multiple Sclerosis Drug Shows Promise for Preventing Heart Failure
Science Daily (press release)
July 16, 2013 — A drug already approved to treat multiple sclerosis may also hold promise for treating cardiac hypertrophy, or thickening of the cardiac muscle-a disorder that often leads to heart failure, researchers at the University of Illinois at

and more »

16Jul/13

MS drug shows promise for preventing heart failure from cardiac hypertrophy – ScienceBlog.com (blog)


ScienceBlog.com (blog)

MS drug shows promise for preventing heart failure from cardiac hypertrophy
ScienceBlog.com (blog)
A drug already approved to treat multiple sclerosis may also hold promise for treating cardiac hypertrophy, or thickening of the cardiac muscle–a disorder that often leads to heart failure, researchers at the University of Illinois at Chicago College